Merck
MRK
$105.70
Share price
1.61%
Change (1 day)
36.25%
Change (1 year)
Categories
Earnings for Merck (MRK)
Earnings in 2022 (TTM): $17.77 B
According to Merck's latest financial reports the company's current earnings (TTM) are $17.77 B. In 2021 the company made an earning of $15.16 B an increase over its 2020 earnings that were of $9.62 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Merck from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $17.77 B | 17.25% |
| 2021 | $15.16 B | 57.55% |
| 2020 | $9.62 B | -22.12% |
| 2019 | $12.35 B | 30.45% |
| 2018 | $9.47 B | 30.2% |
| 2017 | $7.27 B | 35.93% |
| 2016 | $5.35 B | -11.87% |
| 2015 | $6.07 B | -66.29% |
| 2014 | $18.01 B | 183.88% |
| 2013 | $6.34 B | -33.02% |
| 2012 | $9.47 B | 17.21% |
| 2011 | $8.08 B | 241.23% |
| 2010 | $2.36 B | -84.96% |
| 2009 | $15.74 B | 158.81% |
| 2008 | $6.08 B | 8.33% |
| 2007 | $5.61 B | 52.38% |
| 2006 | $3.68 B | -37.08% |
| 2005 | $5.85 B | -11.4% |
| 2004 | $6.61 B | -25.02% |
| 2003 | $8.81 B | -8.78% |
| 2002 | $9.66 B | -0.62% |
| 2001 | $9.72 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $23.03 B | 29.60% | 🇺🇸 USA |
 Novartis NVS | $23.58 B | 32.66% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.92 B | 96.46% | 🇺🇸 USA |
 Abbott Laboratories ABT | $9.31 B | -47.61% | 🇺🇸 USA |
 Eli Lilly LLY | $6.54 B | -63.15% | 🇺🇸 USA |
 Amgen AMGN | $7.72 B | -56.52% | 🇺🇸 USA |
 Sanofi SNY | $8.65 B | -51.32% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $7.71 B | -56.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.58 B | -62.96% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$1.34 B | -107.50% | 🇮🇱 Israel |